Mavacamten (Camzyos) for Obstructive Hypertrophic Cardiomyopathy

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2022年 / 64卷 / 1652期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：89 / 91
页数：3
相关论文
共 50 条
  • [1] Mavacamten for hypertrophic obstructive cardiomyopathy
    Quintana, Eduard
    Bajona, Pietro
    Myers, Patrick O.
    LANCET, 2021, 397 (10272): : 369 - 369
  • [2] Mavacamten (CAMZYOS) First-in-Class Small-Molecule Myosin Inhibitor for Treatment of Obstructive Hypertrophic Cardiomyopathy
    O'Malley, Patricia Anne
    CLINICAL NURSE SPECIALIST, 2024, 38 (03) : 119 - 121
  • [3] Mavacamten for Obstructive Hypertrophic Cardiomyopathy in China
    Desai, Milind Y.
    JAMA CARDIOLOGY, 2023, 8 (10) : 966 - 967
  • [4] Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    Rader, Florian
    Oreziak, Artur
    Choudhury, Lubna
    Saberi, Sara
    Fermin, David
    Wheeler, Matthew T.
    Abraham, Theodore P.
    Garcia-Pavia, Pablo
    Zwas, Donna R.
    Masri, Ahmad
    Owens, Anjali
    Hegde, Sheila M.
    Seidler, Tim
    Fox, Shawna
    Balaratnam, Ganesh
    Sehnert, Amy J.
    Olivotto, Iacopo
    JACC-HEART FAILURE, 2024, 12 (01) : 164 - 177
  • [5] Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension
    Wang, Andrew
    Spertus, John A.
    Wojdyla, Daniel M.
    Abraham, Theodore P.
    Nilles, Ester Kim
    Owens, Anjali Tiku
    Saberi, Sara
    Cresci, Sharon
    Sehnert, Amy
    Lakdawala, Neal K.
    JACC-HEART FAILURE, 2024, 12 (03) : 567 - 579
  • [6] MAVACAMTEN USE FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN AN OCTOGENARIAN
    Chandrasekhar, Sanjay Amrith
    Enciso, Juan
    Casals, Luke R.
    Wu, Robby
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2801 - 2801
  • [7] Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic Cardiomyopathy
    Giudicessi, John R.
    Alsidawi, Said
    Geske, Jeffrey B.
    Newman, Darrell B.
    Arruda-Olson, Adelaide M.
    Bos, j. Martijn
    Ommen, Steve R.
    Ackerman, Michael J.
    MAYO CLINIC PROCEEDINGS, 2024, 99 (02) : 341 - 343
  • [8] Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy
    Zampieri, Mattia
    Argiro, Alessia
    Marchi, Alberto
    Berteotti, Martina
    Targetti, Mattia
    Fornaro, Alessandra
    Tomberli, Alessia
    Stefano, Pierluigi
    Marchionni, Niccolo
    Olivotto, Iacopo
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (07)
  • [9] Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy
    Scholtz, Smita
    Rudolph, Volker
    Reil, Jan-Christian
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [10] Impact of Mavacamten on blood pressure in Hypertrophic Obstructive Cardiomyopathy
    Shehadeh, Mohanad
    Eid, Fahad
    Rahhal, Alaa
    Hanafi, Amir
    Eid, Mohamed
    Baibhav, Bipul
    CIRCULATION, 2024, 150
12345